Form: SCHEDULE 13G

Statement of Beneficial Ownership by Certain Investors

November 14, 2025






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



 
LSV Associates II, LLC
 
Signature:/s/ Travis Boettner
Name/Title:Travis Boettner, Attorney-in-Fact (See Note 1)
Date:11/14/2025
 
Lightstone Ventures II, L.P.
 
Signature:/s/ Travis Boettner
Name/Title:By LSV Associates II, LLC, its General Partner, By Travis Boettner, Attorney-in-Fact (See Note 1)
Date:11/14/2025
 
Lightstone Ventures II (A), L.P.
 
Signature:/s/ Travis Boettner
Name/Title:By LSV Associates II, LLC, its General Partner, By Travis Boettner, Attorney-in-Fact (See Note 1)
Date:11/14/2025
 
Michael A Carusi
 
Signature:/s/ Travis Boettner
Name/Title:By Travis Boettner, Attorney-in-Fact for Michael A. Carusi (See Note 1)
Date:11/14/2025
 
Jean George
 
Signature:/s/ Travis Boettner
Name/Title:By Travis Boettner, Attorney-in-Fact for Jean George (See Note 1)
Date:11/14/2025
 
Henry A. Plain Jr.
 
Signature:/s/ Travis Boettner
Name/Title:By Travis Boettner, Attorney-in-Fact for Henry A. Plain Jr. (See Note 1)
Date:11/14/2025

Comments accompanying signature:  Note 1: Signed pursuant to a Power of Attorney filed as Exhibit 24 to Form 3/A for ALX Oncology Holdings Inc. filed by the Reporting Persons on July 22, 2020.
Exhibit Information

Exhibit 99.1 Joint Filing Agreement